Severe COVID-19 patients exhibit an ILC2 NKG2D+ population in their impaired ILC compartment
Alejandra Gomez‐Cadena, Laurie Spehner, Marie Kroemer, Myriam Ben Khelil, Kévin Bouiller, Grégory Verdeil, Sara Trabanelli, Christophe Borg, Romain Loyon, Camilla Jandus
Abstract
International audience
Topics & Concepts
Coronavirus disease 2019 (COVID-19)Compartment (ship)PandemicVirologyPopulationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakNKG2DBiologyMedicineInternal medicineEnvironmental healthDiseaseOutbreakGeneticsHistoryInfectious disease (medical specialty)Ancient historyCytotoxicityIn vitroIL-33, ST2, and ILC PathwaysEosinophilic EsophagitisImmune Cell Function and Interaction